Trial Profile
ALIQUOT
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2010
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Letrozole (Primary)
- Indications Advanced breast cancer; Breast cancer; Menopause
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms ALIQUOT
- 01 Feb 2010 Results from the effects on bone turnover have been publised in Breast Cancer Research and Treatment.
- 11 Dec 2008 Interim results for the effects of therapy lipid metabolism were presented at the San Antonio Breast Cancer Symposium (SABCS) in December 2008.
- 20 Feb 2007 New trial record.